US Patent Issued to SHANGHAI AUCTA PHARMACEUTICALS on Nov. 25 for "Formulation for lacosamide" (Chinese, American Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,587, issued on Nov. 25, was assigned to SHANGHAI AUCTA PHARMACEUTICALS Co. LTD. (Shanghai).

"Formulation for lacosamide" was invented by Shoufeng Li (Piscataway, N.J.), Ye Huang (Piscataway, N.J.), Fen Ren (Shanghai) and Bolun Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The patent document discloses a dosage form featuring a unique combination of extended-release and immediate-release components of the active ingredient. This dosage form allows for high drug loading, enabling once-daily administration while providing a sustained window of effective treatment with reduced fluctuations in drug concentration. The document also disclo...